Location Symbol Title MIM # Disorder Comments Method Mouse
17q22-q24 CSH1, CSA, PL Chorionic somatomammotropin hormone-1 150200 [Placental lactogen deficiency] (1) REa, A 13(Pl1)
17q22-q24 GH1, GHN Growth hormone-1 139250 Growth hormone deficiency (3); Growth hormone deficiency, isolated,type IA, 262400 (3); Growth hormone deficiency, isolated, type IB, 262400 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome,262650 (3); Short stature, familial, 604271 (3) 5'-GH1-CSHP1-CSH1-GH2-CSH2-3' REa, A, Fd 11(Gh)
17q23 ACE, DCP1, ACE1 Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1) 106180 {Myocardial infarction, susceptibility to} (3); {Alzheimerdisease, susceptibility to}, 104300 (3); {Diabetic nephropathy, susceptibility to}, 603933 (3); [Angiotensin I-converting enzyme, benign serum increase] (3);{SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3) A, H, Fd
17q23 BSZQTL Bone size quantitative trait locus 1 609656 {Bone size QTL} (2) Fd
17q23 CA4, RP17 Carbonic anhydrase IV 114760 Retinitis pigmentosa-17, 600852 (3) REa, A, Fd
17q23 CD79B, IGB, B29 Immunoglobulin-associated protein (B29) 147245 A
17q23 CLTC Clathrin, heavy polypeptide (Hc) 118955 fusion gene with TFE3 in renal adenocarcinoma REc, Ch
17q23 MKS1, MKS, BBS13 MKS1 gene 609883 Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13,209900 (3) frequent in Finland Fd, REc
17q23-q24 POLG2, POLGB, PEOA4 Polymerase, DNA, gamma-2 604983 Progressive external ophthalmoplegia with mitochondrial DNAdeletions, autosomal dominant 4, 610131 (3) REc
17q23-q24 PRKAR1A, TSE1, CNC1, CAR, PPNAD1 Protein kinase, cAMP-dependent, regulatory, type I, alpha 188830 Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);Thyroid carcinoma, papillary, 188550 (3); Pigmented adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic (3) fused with RET to form PTC2 S, M, REa, RE, Fd 11(Tse1)
You are viewing a mobilized version of this site...
View original page here